ClinicalTrials.govpublic full text
A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen
melanoma, sarcoma, gastrointestinal stromal tumor (gist), head and neck cancer, transitional cell carcinoma, prostate cancer, ovarian carcinoma, esophageal cancer, breast cancer, mbv, mixed bacterial vaccine, ny-eso-1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 853191
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.